The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Radiation Therapy Oncology Group (RTOG) 9413: Randomized trial comparing whole pelvic radiotherapy (WPRT) to prostate only (PORT) and neoadjuvant hormone therapy (NHT) to adjuvant hormone therapy (AHT).
Mack Roach
No relevant relationships to disclose
Yan Yan
No relevant relationships to disclose
Colleen Anne Lawton
No relevant relationships to disclose
I-Chow Joe Hsu
No relevant relationships to disclose
Robert A. Lustig
No relevant relationships to disclose
Christopher U. Jones
No relevant relationships to disclose
Marvin Rotman
No relevant relationships to disclose
Kenneth Lee Zeitzer
No relevant relationships to disclose
Maria Werner-Wasik
No relevant relationships to disclose
Harold Kim
No relevant relationships to disclose
Charles R. Thomas
No relevant relationships to disclose
William U. Shipley
No relevant relationships to disclose
Howard Mark Sandler
No relevant relationships to disclose